Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 3Not yet recruiting 2

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Hypoactive Delirium 1Cancer Diagnosis 1Breast Neoplasms 1

Interventions

pembrolizumab 563Specimen Handling 493Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 405Radiotherapy 353Bevacizumab 314Gemcitabine 313Paclitaxel 298Biopsy 292Drug Therapy 284Blood Specimen Collection 248Capecitabine 246Oxaliplatin 241fludarabine 239Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 206Dexamethasone 188Radiosurgery 182Standard of Care 159Rituximab 159Pemetrexed 156Surgical Procedures, Operative 148atezolizumab 146durvalumab 145Leucovorin 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Health Personnel × Clear all
NCT05837039 2026-03-04

A Comparison of Healthcare Provider and Caregiver Perception of Discomfort in Advanced Cancer Patients Who Have a Hypoactive Delirium

M.D. Anderson Cancer Center

Recruiting
100 enrolled

Hypoactive Delirium

NCT07416513 2026-02-18

ALTHEA

European Institute of Oncology

Phase NA Recruiting
200 enrolled

Cancer Diagnosis

NCT06762496 2025-11-28

A New Tool to Promote Patient's Engagement in Their Healthcare Process

European Institute of Oncology

Recruiting
180 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡